The encouraging news
In the first few weeks of treatment, many GLP-1 users experience digestive discomfort, including nausea, vomiting, diarrhea, and stomach pain.6 More often than not, these are related to a GLP-1 receptor agonists ability to slow gastric emptying
people The Boring Company Time Person of the Year Trumpism Twitter, Inc
Interestingly, our live-cell imaging results suggest that CCK peptide does not activate robust increases in intracellular Ca 2+ in mouse -cells as it does in pancreatic acinar cells 30 or vagal afferent neurons 29 and in rat islet 21 , and this lack of an effect on calcium influx may explain the inability to stimulate insulin secretion
HRS Congress 2026 Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival
With Troys guidance, you can feel confident in a safe, effective approach to nonsurgical weight loss that focuses on long-term success